Evidence map›Paper›PMID 29991407›Full record

ArticleThe international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease2018

Blood transcriptomic markers of

K M Dupnik, J M Bean, M H Lee, M A Jean Juste, L Skrabanek, V Rivera, C K Vorkas, J W Pape, D W Fitzgerald, M Glickman

Abstract read
In one paragraph

Article in The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

K M DupnikDepartment of Medicine, Weill Cornell Medical College, New York, New York.
J M BeanImmunology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
M H LeeDepartment of Medicine, Weill Cornell Medical College, New York, New York.
M A Jean JusteGHESKIO (Groupe Haitien d'Etude du Sarcome de Kaposi et des Infections Opportunistes) Center, Port au Prince, Haiti.
L SkrabanekApplied Bioinformatics Core and Department of Physiology and Biophysics, Weill Cornell Medicine, New York, New York.
V RiveraDepartment of Medicine, Weill Cornell Medical College, New York, New York.
C K VorkasDepartment of Medicine, Weill Cornell Medical College, New York, New York, Immunology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
J W PapeDepartment of Medicine, Weill Cornell Medical College, New York, New York, GHESKIO (Groupe Haitien d'Etude du Sarcome de Kaposi et des Infections Opportunistes) Center, Port au Prince, Haiti.
D W FitzgeraldDepartment of Medicine, Weill Cornell Medical College, New York, New York.
M GlickmanImmunology Program, Memorial Sloan Kettering Cancer Center, New York, New York, USA, Division of Infectious Diseases, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Nicholas D Socci · 1985 to 2026
$347.4M
Viable but Nonculturable MtbU19AI111143 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI GLICKMAN, MICHAEL S, NATHAN, CARL FRANCIS · 2014 to 2020
$48.6M
Clinical and Translational Science CenterUL1TR000457 · NCATS · WEILL MEDICAL COLL OF CORNELL UNIV · PI IMPERATO-MCGINLEY, JULIANNE L · 2012 to 2016
$46.0M
T32: Pathogenesis of Infectious Diseases Training ProgramT32AI007613 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI ROY M. GULICK · 1999 to 2026
$8.8M
Training in pharmacokinetic and pharmacodynamics research in HIV and tuberculosisD43TW010062 · FIC · WEILL MEDICAL COLL OF CORNELL UNIV · PI FITZGERALD, DANIEL W · 2015 to 2019
$1.8M
Global Health Research Training in HIV and TuberculosisK24AI098627 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI FITZGERALD, DANIEL W · 2012 to 2022
$1.8M
Host susceptibility to Mycobacterium tuberculosis recurrence in HIV-infected peopleK23AI131913 · NIAID · WEILL MEDICAL COLL OF CORNELL UNIV · PI DUPNIK, KATHRYN M · 2018 to 2022
$964k
FIC NIH HHS D43 TW010062NCATS NIH HHS UL1 TR000457NCI NIH HHS P30 CA008748NIAID NIH HHS K23 AI131913NIAID NIH HHS K24 AI098627NIAID NIH HHS T32 AI007613NIAID NIH HHS U19 AI111143
6 · The paper itself

Abstract

backgroundPeripheral blood transcriptome signatures that distinguish active pulmonary tuberculosis (TB) from control groups have been reported, but correlations of these signatures with sputum mycobacterial load are incompletely defined.

methodsWe assessed the performance of published TB transcriptomic signatures in Haiti, and identified transcriptomic biomarkers of TB bacterial load in sputum as measured by Xpert® MTB/RIF molecular testing. People in Port au Prince, Haiti, with untreated pulmonary TB (n = 51) formed the study cohort: 19 people with low and 32 with high sputum Mycobacterium tuberculosis load. Peripheral whole blood transcriptomes were generated using RNA sequencing.

resultsTwenty of the differentially expressed transcripts in TB vs. no TB were differentially expressed in people with low vs. high sputum mycobacterial loads. The difference between low and high bacterial load groups was independent of radiographic severity. In a published data set of transcriptomic response to anti-tuberculosis treatment, this 20-gene subset was more treatment-responsive at 6 months than the full active TB signature.

conclusionWe identified genes whose transcript levels in the blood distinguish active TB with high vs. low M. tuberculosis loads in the sputum. These transcripts may reveal mechanisms of mycobacterial control of M. tuberculosis during active infection, as well as identifying potential biomarkers for bacterial response to anti-tuberculosis treatment.

Indexed as

TranscriptomeAdultBacterial LoadBiomarkersCase-Control StudiesFemaleHaitiHumansMaleMycobacterium tuberculosisSensitivity and SpecificitySequence Analysis, RNASputumTuberculosis, PulmonaryBiomarkers

Identifiers

PMID29991407
PMCPMC6343854

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.